홈 › 전이성 암 › 텍사스

텍사스의 전이성 암 임상 시험

전이성 암 관련 연구 137개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NEXT Houston, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07693751

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Dallas
Clinical Study Site, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07335497

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

M D Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05195710

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

UT MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05111561

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

UT MD Anderson Cancer Center, Houston

피험자 모집 중1상

12세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05372640

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

The University of Texas MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07458347

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hendrick Medical Center, Abilene
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Lyndon Baines Johnson General Hospital, Houston
외 2개

피험자 모집 중2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

UT MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05372614

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Mary Crowley Cancer Research Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04886804

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07020221

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Old Parkland Hospital Hematology Oncology Clinic, Dallas
UT Southwestern Medical Center, Dallas
DHR Health Oncology Institute, Edinburg
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06216301

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Mary Crowley Cancer Research, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT05394103

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

University of Texas Southwestern Medical Center, Dallas
Houston Methodist Cancer Center, Houston
The University of Texas M.D. Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Texas Oncology - West Texas, Abilene
Texas Oncology - Austin, Austin
Texas Oncology - San Antonio, San Antonio
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07562152

CREO - Microwave Ablation Feasibility Study

Memorial Hermann-Texas Medical Center, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07817147

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas at Tyler, Tyler

피험자 모집 중1상

18세 ~ 99세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06983743

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

The Cancer Therapy and Research Center at UTHSCSA, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07098806

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NEXT Oncology, Austin
UT Southwestern, Dallas

피험자 모집 중1상

19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

Community Clinical Trials, Kingwood

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06824064

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Hendrick Medical Center, Abilene
World Research Link, Baytown
Parkland Health and Hospital System, Dallas
외 10개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

USO-Texas Oncology-Central/South Texas, Austin
UT Southwestern Medical Center, Dallas
US Oncology, The Woodlands
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213804

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

M.D. Anderson Children's Cancer Hospital, Houston

피험자 모집 중2상

8세 ~ 30세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05726383

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

The University of Texas MD Anderson Cancer Center (site 127), Houston

피험자 모집 중1/2상

18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT03556228

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Texas Oncology, Austin
William Beaumont Army Medical Center, Fort Bliss
Houston Methodist Hospital, Houston
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of Texas Southwestern, Dallas
Texas Oncology, P.A, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05614739

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

University of Texas Southwestern Medical Center, Dallas

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981

A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

START San Antonio, LLC, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07903415

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Austin
Clinical Study Site, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07909031

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

M D Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT05475171

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07283731

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START Dallas Fort Worth, Fort Worth
University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07262619

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06943755

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

University of Texas Southwestern Medical Center, Dallas

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06601296

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

NEXT Oncology Dallas, Irving

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07094204

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

The Univeristy of Texas Md Anderson Cancer Center, Houston

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06127407

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.